Tag: Anticoagulants
NIH Launches Clinical Trials of Antithrombotics for COVID-19
Adaptive design allows evaluation of various doses, types of blood thinners in outpatients, inpatients
CYP2C19 Genotyping May Aid Antiplatelet Prescribing
Benefit only seen for composite outcome, not for major or minor bleeding incidents
Mortality, Intubation Rates Lower With Anticoagulation in COVID-19
Thromboembolic disease that was not suspected clinically identified in 42 percent of autopsies
High Rates of DVT Seen in Critically Ill COVID-19 Patients
Authors call for prompt detection and early anticoagulant therapy
Osteoporotic Fracture Risk Lower for DOAC Than Warfarin in A-Fib
No differences seen in fracture risk in head-to-head comparisons of direct oral anticoagulants
Anticoagulation May Improve Outcomes in COVID-19 Patients
Longer duration of AC treatment linked to reduced risk for mortality in hospitalized patients
Thromboembolic Complications in COVID-19 Discussed
All hospitalized COVID-19 patients should be started on prophylactic low-molecular-weight heparin
Quality Improvement Effort Cuts Blood Clots in Brain Injury Patients
Prophylactic anticoagulation protocol improves patient outcomes
Rivaroxaban Prevents VTE After Lower-Limb Surgery
Rivaroxaban superior to enoxaparin for preventing major VTE after nonmajor orthopedic surgery
Dual Therapy Linked to Lower Bleeding Risk in A-Fib After PCI
Low-certainty evidence showed inconclusive effects for all-cause mortality, cardiovascular mortality, MI
